Fulltext

Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications

Madjdpour, C. ; Spahn, D. R.

In: British Journal of Anaesthesia, 2005, vol. 95, no. 1, p. 33-42

Aggiungi alla tua lista
    Titre
    • Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications
    Auteur
    • Madjdpour, C.. Department of Anaesthesiology, University Hospital Lausanne, Switzerland
    • Spahn, D. R.. Department of Anaesthesiology, University Hospital Lausanne, Switzerland
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • British Journal of Anaesthesia, 2005, vol. 95, no. 1, p. 33-42. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:296873
    Summary
    Careful assessment of risks and benefits has to precede each decision on allogeneic red blood cell (RBC) transfusion. Currently, a number of key issues in transfusion medicine are highly controversial, most importantly the influence of different transfusion thresholds on clinical outcome. The aim of this article is to review current evidence on blood transfusions, to highlight ‘hot topics' with respect to efficacy, outcome and risks, and to provide the reader with transfusion guidelines. In addition, a brief synopsis of transfusion alternatives will be given. Based on up-to-date information of current evidence, together with clinical knowledge and experience, the physician will be able to make transfusion decisions that bear the lowest risk for the patient